Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0130-2019

Drug recall · October 31, 2018

Lidocaine 1% + Epinephrine 1:100 recall

Why: Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450

Lots / codes

Lot# 04042018:58, Exp 10/17/18

Quantity
395 vials
Company
RXQ Compounding LLC, Athens, OH
Distribution
U.S.A. nationwide
Initiated
September 25, 2018 · Voluntary: Firm initiated
Classified
November 1, 2018
Reported
October 31, 2018
Ended
October 18, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Epinephrine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.